These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26361155)

  • 1. How Does Elevated Lipoprotein(a) Cause Aortic Valve Stenosis?
    Nordestgaard BG; Langsted A
    J Am Coll Cardiol; 2015 Sep; 66(11):1247-1249. PubMed ID: 26361155
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.
    Capoulade R; Chan KL; Yeang C; Mathieu P; Bossé Y; Dumesnil JG; Tam JW; Teo KK; Mahmut A; Yang X; Witztum JL; Arsenault BJ; Després JP; Pibarot P; Tsimikas S
    J Am Coll Cardiol; 2015 Sep; 66(11):1236-1246. PubMed ID: 26361154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.
    Zheng KH; Tsimikas S; Pawade T; Kroon J; Jenkins WSA; Doris MK; White AC; Timmers NKLM; Hjortnaes J; Rogers MA; Aikawa E; Arsenault BJ; Witztum JL; Newby DE; Koschinsky ML; Fayad ZA; Stroes ESG; Boekholdt SM; Dweck MR
    J Am Coll Cardiol; 2019 May; 73(17):2150-2162. PubMed ID: 31047003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis.
    Yeang C; Wilkinson MJ; Tsimikas S
    Curr Opin Cardiol; 2016 Jul; 31(4):440-50. PubMed ID: 27205885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Ma GS; Wilkinson MJ; Reeves RR; Yeang C; DeMaria AN; Cotter B; Patel M; Mahmud E; Tsimikas S
    Angiology; 2019 Apr; 70(4):332-336. PubMed ID: 30700108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological significance of lipoprotein(a) in aortic valve stenosis.
    Yu B; Khan K; Hamid Q; Mardini A; Siddique A; Aguilar-Gonzalez LP; Makhoul G; Alaws H; Genest J; Thanassoulis G; Cecere R; Schwertani A
    Atherosclerosis; 2018 May; 272():168-174. PubMed ID: 29614432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) and calcific aortic valve stenosis: A systematic review.
    Guddeti RR; Patil S; Ahmed A; Sharma A; Aboeata A; Lavie CJ; Alla VM
    Prog Cardiovasc Dis; 2020; 63(4):496-502. PubMed ID: 32526213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcific Aortic Valve Stenosis and Atherosclerotic Calcification.
    de Oliveira Sá MPB; Cavalcanti LRP; Perazzo ÁM; Gomes RAF; Clavel MA; Pibarot P; Biondi-Zoccai G; Zhigalov K; Weymann A; Ruhparwar A; Lima RC
    Curr Atheroscler Rep; 2020 Jan; 22(2):2. PubMed ID: 31912380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of lipoprotein (a) and LPA KIV2 repeat polymorphism in bicuspid aortic valve stenosis and calcification: a proof of concept study.
    Sticchi E; Giusti B; Cordisco A; Gori AM; Sereni A; Sofi F; Mori F; Colonna S; Fugazzaro MP; Pepe G; Nistri S; Marcucci R
    Intern Emerg Med; 2019 Jan; 14(1):45-50. PubMed ID: 30099661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Threshold effect for lipoprotein(a) in aortic stenosis.
    Tzolos E; Dweck MR
    Heart; 2021 Sep; 107(17):1367-1368. PubMed ID: 34021037
    [No Abstract]   [Full Text] [Related]  

  • 11. New Frontiers in Lp(a)-Targeted Therapies.
    Borrelli MJ; Youssef A; Boffa MB; Koschinsky ML
    Trends Pharmacol Sci; 2019 Mar; 40(3):212-225. PubMed ID: 30732864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoB/ApoA-I Ratio is Associated With Faster Hemodynamic Progression of Aortic Stenosis: Results From the PROGRESSA (Metabolic Determinants of the Progression of Aortic Stenosis) Study.
    Tastet L; Capoulade R; Shen M; Clavel MA; Côté N; Mathieu P; Arsenault M; Bédard É; Tremblay A; Samson M; Bossé Y; Dumesnil JG; Arsenault BJ; Beaudoin J; Bernier M; Després JP; Pibarot P
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29440006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease.
    Nsaibia MJ; Mahmut A; Boulanger MC; Arsenault BJ; Bouchareb R; Simard S; Witztum JL; Clavel MA; Pibarot P; Bossé Y; Tsimikas S; Mathieu P
    J Intern Med; 2016 Nov; 280(5):509-517. PubMed ID: 27237700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the ultimate test that lowering lipoprotein(a) is beneficial for cardiovascular disease and aortic stenosis?
    Hung MY; Tsimikas S
    Curr Opin Lipidol; 2014 Dec; 25(6):423-30. PubMed ID: 25340480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) levels are associated with aortic valve calcification in asymptomatic patients with familial hypercholesterolaemia.
    Vongpromek R; Bos S; Ten Kate GJ; Yahya R; Verhoeven AJ; de Feyter PJ; Kronenberg F; Roeters van Lennep JE; Sijbrands EJ; Mulder MT
    J Intern Med; 2015 Aug; 278(2):166-73. PubMed ID: 25487646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) in clinical practice: New perspectives from basic and translational science.
    Scipione CA; Koschinsky ML; Boffa MB
    Crit Rev Clin Lab Sci; 2018 Jan; 55(1):33-54. PubMed ID: 29262744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Fetuin-A on progression of calcific aortic valve stenosis - The COFRASA - GENERAC study.
    Kubota N; Testuz A; Boutten A; Robert T; Codogno I; Duval X; Tubiana S; Hekimian G; Arangalage D; Cimadevilla C; Kerneis C; Vahanian A; Messika-Zeitoun D
    Int J Cardiol; 2018 Aug; 265():52-57. PubMed ID: 29885700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a) is robustly associated with aortic valve calcium.
    Kaiser Y; Singh SS; Zheng KH; Verbeek R; Kavousi M; Pinto SJ; Vernooij MW; Sijbrands EJG; Boekholdt SM; de Rijke YB; Stroes ESG; Bos D
    Heart; 2021 Sep; 107(17):1422-1428. PubMed ID: 33963048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidized Phospholipids and Risk of Calcific Aortic Valve Disease: The Copenhagen General Population Study.
    Kamstrup PR; Hung MY; Witztum JL; Tsimikas S; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1570-1578. PubMed ID: 28572160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression: A Systematic Review and Meta-Analysis.
    Arsenault BJ; Loganath K; Girard A; Botezatu S; Zheng KH; Tzolos E; Abdoun K; Tastet L; Capoulade R; Côté N; Craig N; Chan KL; Tam JW; Teo KK; Couture C; Clavel MA; Mathieu P; Thériault S; Stroes ESG; Newby DE; Tsimikas S; Pibarot P; Dweck MR
    JAMA Cardiol; 2024 Sep; 9(9):835-842. PubMed ID: 39018080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.